Top Page
Beamtree Holdings Ltd
(Sydney:BMT)
Beamtree Holdings Ltd (BMT) vs. iShares MSCI Australia ETF (EWA)
Beamtree Holdings Ltd Business Overview & Revenue Model
Beamtree Holdings Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.60M | 28.60M | 27.60M | 22.77M | 16.55M | 8.39M |
| Gross Profit | 4.91M | 28.60M | 4.89M | 2.14M | -202.00K | 2.77M |
| EBITDA | -4.68M | -808.00K | -331.00K | -1.26M | -2.28M | 1.02M |
| Net Income | -6.16M | -6.16M | -5.11M | -6.91M | -4.45M | -383.62K |
Balance Sheet | ||||||
| Total Assets | 54.29M | 54.29M | 59.65M | 62.53M | 63.91M | 47.05M |
| Cash, Cash Equivalents and Short-Term Investments | 4.78M | 4.78M | 5.04M | 8.81M | 6.35M | 14.12M |
| Total Debt | 3.26M | 3.26M | 1.66M | 755.00K | 1.12M | 799.36K |
| Total Liabilities | 12.36M | 12.36M | 12.52M | 15.31M | 15.33M | 4.96M |
| Stockholders Equity | 41.93M | 41.93M | 47.14M | 47.22M | 48.58M | 42.09M |
Cash Flow | ||||||
| Free Cash Flow | 440.00K | -1.84M | -4.51M | -1.88M | -4.83M | -2.64M |
| Operating Cash Flow | 609.00K | 609.00K | -492.00K | 768.00K | -2.32M | 240.65K |
| Investing Cash Flow | -2.45M | -2.45M | -4.02M | -2.65M | -5.16M | -2.98M |
| Financing Cash Flow | 1.58M | 1.58M | 749.00K | 4.34M | -286.00K | 12.65M |
Beamtree Holdings Ltd Technical Analysis
Beamtree Holdings Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | AU$127.58M | 79.17 | 1.89% | ― | 10.06% | ― | |
| ― | AU$87.68M | ― | -8647.54% | ― | 25.98% | 21.43% | |
| ― | AU$23.07M | 140.00 | -17.05% | ― | 28.91% | -1050.00% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | $69.32M | ― | -12.35% | ― | 15.99% | 22.05% | |
| ― | AU$61.03M | -9.86 | -13.83% | ― | 3.61% | -17.03% | |
| ― | AU$17.71M | 110.00 | -240.60% | ― | -48.41% | -7200.00% |
Beamtree Holdings Ltd Corporate Events
Beamtree Holdings Limited has announced its Annual General Meeting (AGM) scheduled for November 27, 2025, in Sydney. The company has provided details on how shareholders can participate, either in person or virtually, and emphasized the importance of voting on resolutions. This announcement underscores Beamtree’s commitment to engaging with its shareholders and maintaining transparency in its operations.
The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Ltd announced the cessation of 2,800,000 performance rights due to unmet conditions, as of October 10, 2025. This development may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational execution and strategic direction.
The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Ltd has announced the issuance of 200,000 performance rights under an employee incentive scheme, which are not intended to be quoted on the ASX. This move is part of the company’s strategy to incentivize and retain talent, potentially impacting its operational efficiency and market competitiveness positively.
The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Limited has announced a change in the director’s interest notice, specifically regarding Stuart McDonald. On October 15, 2025, McDonald acquired 200,000 fully paid ordinary shares at $0.23 per share through an on-market trade. This change reflects an increase in McDonald’s direct interest in the company, potentially indicating confidence in Beamtree Holdings’ future performance.
The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Limited has announced the appointment of Stuart MacDonald as a director, effective from October 15, 2025. The announcement indicates that MacDonald currently holds no relevant interests in securities as either a registered holder or through contracts, suggesting a straightforward appointment without immediate financial implications for the company or its stakeholders.
The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Limited reported a 9% increase in recurring revenue for Q1 FY26, driven by growth across all product lines, including a significant clinical coding audit contract in Singapore and new contracts for its PICQ Audit and Rippledown solutions. The company is advancing its strategic roadmap with international market expansions, including the deployment of an autonomous clinical coding solution and a collaboration with the NHS Confederation in the UK. The appointment of Stuart MacDonald as a Non-Executive Director is expected to aid in scaling Beamtree’s product offerings and international growth. Despite a reduction in cash reserves due to software investment, Beamtree remains confident in its ability to deliver continued financial improvement through disciplined cost management and strategic capital allocation.
The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Ltd has announced the issuance of 39,104 ordinary fully paid shares under its Employee Incentive Plan, as part of salary contribution arrangements. This move reflects the company’s commitment to employee engagement and retention, potentially strengthening its operational capabilities and competitive positioning in the technology and healthcare data solutions market.
The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Limited has announced that its Annual General Meeting will take place on November 27, 2025, in Sydney. The company has set October 16, 2025, as the deadline for director nominations. This meeting is a significant event for stakeholders as it provides an opportunity to discuss the company’s strategic direction and future initiatives, potentially impacting its operations and market positioning.
The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Ltd has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement confirms the company’s compliance with the ASX Corporate Governance Council’s recommendations, detailing the roles and responsibilities of the board and management, and the accountability of the company secretary. This announcement reinforces Beamtree’s commitment to maintaining high governance standards, potentially enhancing its reputation and trust among stakeholders.
The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Ltd has released its audited annual results for FY25, highlighting its ongoing commitment to leveraging data analytics for improved decision-making in healthcare. The announcement underscores the company’s strategic positioning in the market, with potential implications for stakeholders as it continues to innovate and expand its offerings.
The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Ltd’s annual report for 2025 highlights significant financial growth, with a 78% increase in operating profit and a 20% rise in international revenue. The report underscores the company’s strong market positioning and potential for continued expansion, driven by its commitment to enhancing healthcare technology solutions.
The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Limited has secured a $1 million contract with the Ministry of Health in Singapore to conduct a clinical coding and documentation audit across 20 hospitals. This project, which highlights Beamtree’s expertise in the hospital clinical coding market, will utilize their key software products, PICQ and RISQ, to enhance data quality and management. The contract is expected to contribute significantly to Beamtree’s revenue and further solidify its position in the global healthcare sector.
The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
Beamtree Holdings Limited has announced that its FY25 Full Year Results will be released on 28 August 2025, with an investor webinar scheduled for the same day. This announcement highlights Beamtree’s commitment to transparency and engagement with its stakeholders, potentially impacting its market positioning by showcasing its financial health and strategic direction.
The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.